X., Bachovchin, W., Zukowska, Z., and Osborn, J
Could popular weight-loss drugs help treat addiction and dementia
Cell Death Dis 2011;2:e164.Google Scholar Ghandehari-Alavijeh, R, Tavalaee, M, Zohrabi, D, Foroozan-Broojeni, S, Abbasi, H, Nasr-Esfahani, MH
Questions worth asking include What factors do you consider when deciding if this medication is right for me Are there medical conditions or medications that could affect how this works for me How does my health history influence this decision Guidance from organizations such as the American Diabetes Association and the Endocrine Society emphasizes shared decision making and individualized assessment when initiating incretin based therapies as part of obesity care
This effect is consistent with what has been observed with other GLP-1 based compounds and is thought to reflect a combination of weight-mediated reduction in vascular resistance and direct vascular effects of GLP-1 receptor activation
1 person found this helpful